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Background: Complex fractionated atrial electrograms (CFAE) acquired during atrial
fibrillation (AF) are commonly assessed using the discrete Fourier transform (DFT),
but this can lead to inaccuracy. In this study, spectral estimators derived by
averaging the autocorrelation function at lags were compared to the DFT.
Method: Bipolar CFAE of at least 16 s duration were obtained from pulmonary vein
ostia and left atrial free wall sites (9 paroxysmal and 10 persistent AF patients). Power
spectra were computed using the DFT and three other methods: 1. a novel spectral
estimator based on signal averaging (NSE), 2. the NSE with harmonic removal (NSH),
and 3. the autocorrelation function average at lags (AFA). Three spectral parameters
were calculated: 1. the largest fundamental spectral peak, known as the dominant
frequency (DF), 2. the DF amplitude (DA), and 3. the mean spectral profile (MP),
which quantifies noise floor level. For each spectral estimator and parameter, the
significance of the difference between paroxysmal and persistent AF was
determined.
Results: For all estimators, mean DA and mean DF values were higher in persistent
AF, while the mean MP value was higher in paroxysmal AF. The differences in means
between paroxysmals and persistents were highly significant for 3/3 NSE and NSH
measurements and for 2/3 DFT and AFA measurements (p<0.001). For all estimators,
the standard deviation in DA and MP values were higher in persistent AF, while the
standard deviation in DF value was higher in paroxysmal AF. Differences in standard
deviations between paroxysmals and persistents were highly significant in 2/3 NSE
and NSH measurements, in 1/3 AFA measurements, and in 0/3 DFT measurements.
Conclusions: Measurements made from all four spectral estimators were in
agreement as to whether the means and standard deviations in three spectral
parameters were greater in CFAEs acquired from paroxysmal or in persistent AF
patients. Since the measurements were consistent, use of two or more of these
estimators for power spectral analysis can be assistive to evaluate CFAE more
objectively and accurately, which may lead to improved clinical outcome. Since the
most significant differences overall were achieved using the NSE and NSH estimators,
parameters measured from their spectra will likely be the most useful for detecting
and discerning electrophysiologic differences in the AF substrate based upon
frequency analysis of CFAE.
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The dominant frequency (DF) is an important measure for assessing complex frac-
tionated atrial electrograms (CFAE) in patients with atrial fibrillation (AF) [1-3].
CFAE are defined as electrograms composed of ≥ 2 deflections per cycle without re-
turn to the isoelectric interval, or having a cycle length < 120 ms, as averaged over
a 10 s recording period [4]. Studies have shown that use of radiofrequency catheter
ablation at CFAE regions may be assistive in eliminating the arrhythmogenic sub-
strate by which AF is inducible and perpetuates [4]. CFAE can be analyzed compu-
tationally using time domain [5,6] or frequency domain methods [2,3,7]. However,
time and frequency methods of digital signal analysis do not have equal robustness.
When amplitude varies randomly, as can be common in CFAE recordings, time do-
main methods lose performance for characterizing AF electrograms, while frequency-
domain methods remain stable [8].
The DF can be defined as the tallest fundamental spectral peak within the electro-
physiologic range [7,9]. The inverse of this frequency is, to a first approximation, the
atrial activation rate [10,11]. For DF calculation, electrograms are traditionally
preprocessed by digital bandpass filtering and rectification of the signal, followed by
additional low pass filtering [3,12,13]. The preprocessing step generates a smoothed sig-
nal that is proportional to the amplitude of the high-frequency components in the ori-
ginal atrial electrogram [12,13]. This enhances the presence of periodicity or
nonperiodicity in the waveform [14] by transforming sharp biphasic deflections into
sinusoidal-like shapes, with the result that the fundamental frequency is more likely to
correspond to the atrial rate [10,15]. However, amplitude and frequency variability can
significantly degrade DF measurement of the preprocessed signals when the discrete
Fourier transform (DFT) is used [15-17], and thus the preprocessing step is sometimes
skipped [18].
Recently, a novel spectral estimator (NSE), derived from a mathematical transform
having an orthogonal, data-driven basis [19], was applied to CFAE for frequency ana-
lysis [19,20]. Since the basis is data-driven, it is estimative of all digital signal compo-
nents, including the sharp biphasic deflections commonly present in electrograms,
without the need to resort to the distortive preprocessing step that is often used for
DFT analysis. Although subharmonics and cross-terms are not significant for DFT ana-
lysis because the Fourier basis is sinusoidal and antisymmetric, they may be significant
in NSE spectra [21]. In this study, spectral estimators derived from the aforementioned
signal averaging transform were implemented to compare performance versus the DFT
for discerning differences in paroxysmal versus persistent AF data.
Method
Clinical data and the electrophysiology procedure
Atrial electrograms were recorded in 19 patients referred to the Columbia University
Medical Center cardiac electrophysiology laboratory for catheter ablation of AF. These
recordings were obtained for prospective analysis as approved by the Institutional Re-
view Board, but analyzed retrospectively for this study. Nine patients had documented
clinical paroxysmal AF, and normal sinus rhythm was their baseline cardiac rhythm in
the electrophysiology laboratory. Atrial fibrillation was induced in these patients by
burst atrial pacing from the coronary sinus or right atrial lateral wall, and was required
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persistent AF without interruption for from several months to years prior to their cath-
eter mapping and ablation procedure. Bipolar atrial mapping was performed with a
NaviStar ThermoCool catheter, 7.5F, 3.5 mm tip, with 2 mm spacing between bipoles
(Biosense-Webster Inc, Diamond Bar, CA, USA). The electrogram signals were ac-
quired using the General Electric CardioLab system (GE Healthcare, Waukesha, WI),
and filtered at acquisition from 30-500 Hz with a single-pole bandpass filter to remove
baseline drift and high frequency noise. The filtered signals were sampled at 977 Hz
and stored. Although the bandpass high end was slightly above the Nyquist frequency,
negligible CFAE signal energy resides in this frequency range [9].
Only signals identified as CFAEs by two cardiac electrophysiologists were included
for analysis. CFAE recordings of at least 16 s in duration were obtained from two sites
outside the ostia of each of the four pulmonary veins and from two left atrial free wall
sites, one in the mid posterior wall, and another on the anterior ridge at the base of the
left atrial appendage. The mapping catheter was navigated at these locations until a
CFAE site was identified. A total of 204 digitized sequences – 90 from paroxysmal and
114 from longstanding AF patients, all meeting the criteria for CFAE, were selected for
this study and included for computational analysis. As in previous studies, to
standardize the morphological characteristics, all digital CFAE signals were normalized
to mean zero and unity variance (average level = 0 volts, standard deviation and vari-
ance = 1) [19-21]. Short signal segments were considered to also be approximately
mean zero and unity variance, so that the autocovariance and autocorrelation functions
were considered to be equivalent.
Power spectral generation using ensemble averaging
NSE spectra were generated as described in detail previously [7,9,19-21] and mentioned
briefly here. In the equations below, underline signifies a vector, a capital letter indi-
cates a matrix, and the first subscript denotes the vector or matrix dimension. A signal




xw;i; i ¼ 1 to n ð1Þ














where ‘int’ is the integer function (the real number is rounded down). Examples of the
summation of signal segments of lengths w = 100, 200, and 500 are shown in Figure 1.
If the signal is 2000 discrete sample points long as in Figure 1, then to form the ensem-
ble average, according to Eq. 3 there would be n = 20 segments of length w = 100, n =
10 segments of length w = 200, and n = 4 segments of length w = 500. The first four
Figure 1 A. CFAE and its first four signal segments with w = 100, 200, and 500. Arrows show some of
the relationships of the signal segments with respect to the original signal at top.
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when w = 500. By summing all n segments, and dividing by n, the ensemble average of
signal segments of length w is obtained. The ensemble average power is then given by:

















xTw; i ⋅ xw; j i ¼ 1 to n; j ¼ 1 to n ð4cÞ
It is evident from Eq. 4c that the ensemble average power is related to the autocorrel-ation function. Suppose a segment length w = 500 and signal length N = 2000 as de-
scribed in Figure 1. Then from Eq. 3, n = 4. Since in Eq. 4c the indices will then be
given by i = 1 to 4 and j = 1 to 4, the phase lags between the four signal segments are
given by:
i ∖ j 1 2 3 4
1 0 1 2 3
2 1 0 1 2
3 2 1 0 1




77775 ¼ lags matrix ð5Þ
where each matrix element is the absolute difference in phase lag between segment i
and segment j. Thus there is no lag w when i = j (lag = 0w), there is one lag between
segments when the indices are separated by 1 (lag = 1w), two lags when the indices
are separated by 2 (lag = 2w), and three lags when the indices are separated by 3
(lag = 3w). Hence, the contribution toward averaging the autocorrelation function in
Eq. 4 is a nonunity weighting of lags, i.e., 0w: 4, 1w: 6, 2w: 4, and 3w: 2. Eq. 4 makes
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son, the autocorrelation function r is computed as the inner product of signal compo-
nents separated by the same phase lag ϕ:
r w; kð Þ ¼ 1
N





xTw; i ⋅ xw; iþk i ¼ 1 to n ð6bÞ
where ϕ = kw. In Eq. 6b, the autocorrelation function is described as a summation of
inner products of signal segment pairs having length w, with segment xw;iþk being
shifted by k segment lengths (kw sample points) from segment xTw;i . The lags matrix of
Eq. 5 shows that the NSE estimator is an unequally weighted average of the autocorrel-
ation function. To include all lags kw, k = 1 to n, so that there is equal weighting when
forming an average autocorrelation function, Eq. 6a can be modified as:











xTw;i ⋅ xw; iþk i ¼ 1 to n; k ¼ 1 to n ð7bÞ
where rav(w) is the autocorrelation function average for all lags ϕ = kw, k = 1 to n,
Eq. 7 is computed over an interval 2N, and Eq. 7b shows the form when segments of
length w are summed. Figure 2 illustrates the process of using this average autocorrelationFigure 2 Mechanism by which the average autocorrelation spectrum sharpens as n lags are added
to form the average. A. The autocorrelation function. B. Lag vectors. The frequency range shown in
panels C and D, 2-20 Hz, corresponds to w = 500–50 sample points for the signal digitized at 977 Hz.
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correlation function xTN ⋅ xN ; φ ¼ k⋅w , as calculated using Eq. 6. A plot of r(w,1) versus
frequency:
f ¼ sample rate
w
ð8Þ
is useful as a rough spectral estimator [22-24]. Figure 2A is such a plot except that the
abscissa should be converted to a frequency scale using Eq. 8. The process of using the
autocorrelation function average as a spectral estimator is shown in Figure 2B. The traces
from left to right in the three panels of Figure 2B are constructed using Eq. 7A, with
k = 1, 2, and 3, respectively, in the range w = 1 to 500. The abscissa in the respective
panels from left to right in Figure 2B has units of lag kw, for 1w, 2w, and 3w. When the
three traces in panel B (lags 1w, 2w, 3w), as well as traces for lags 4w, 5w, …, 16w (not
shown), are overlapped, the result is depicted in panel C, with the abscissa being in units
of Hz (Eq. 8, sample rate 977 Hz). Note that at some frequencies the traces in panel C are
reinforced, whereas at other frequencies they are not. When the traces for all lags are
summed, as in Eq. 7, the result is shown in Figure 2D, which is the power spectrum based
on equally-weighted averaging of the autocorrelation function. The tallest peak occurs at
approximately 6.6 Hz, while the second harmonic is at 13.2 Hz and the second subhar-
monic is at approximately 3.3 Hz. As k increases in Eq. 7, the added component becomes
sharper (left to right in Figure 2B), thus contributing fine detail to the spectrum of
Figure 2D. This is because a much longer portion kw of the signal, w = 1 to 500, is used
for calculation when k is large, with faster falloff away from correlated lags. Where the
deflections of individual traces reinforce in panel C, they become spectral peaks in panel
D. Where reinforcement occurs, there is a correlation between the signal at most or all
lags kw.
To implement Eq. 7 in computer software, the following line of software code can be
used:
rav wð Þ ¼ rav wð Þ þ x ið Þ ⋅ x iþ kwð Þ i ¼ 1 to N ; k ¼ 1 to n ð9Þ
where x(i) is a discrete point in the signal and x(i+kw) is a point, shifted by i+kw for
lags lw, 2w, …, nw. This spectral estimator is normalized as rav(w)/ nN and plotted
versus frequency as calculated using Eq. 8, and is termed the AFA estimator.
The method for construction of lag vectors which are used to form the AFA estimate
is shown in more detail in Figure 3. Lag 1w is depicted in panel A and is the same as
Figure 2B, left-hand panel. For reference, the frequency scale for a sampling rate of 977
Hz, as well as the segment length w, is shown on the abscissa. Letting lag 1w range
from 1 to 500, corresponding to a frequency of 977 – 1.95 Hz, the lag vector contains
500 points in total. The construction of the lag 2w vector is depicted in panel B. The
500 indices have doubled in value as compared with panel A, and now range from 2 to
1000. Examples of corresponding index numbers for lags 1w and 2w are shown as solid
circles in the graphs of panels A and B, respectively. To form the lag 2w vector, the 500
points with lag 2w are extracted from the trace in Figure 3B and plotted, with the result
being the middle graph in Figure 2B. This lag vector contributes a sharper set of fea-
tures to the overall spectral estimate of Figure 2D. Similarly to construct the lag 3w
vector, the 500 points with lag 3w are extracted from the trace in Figure 3C and
Figure 3 Construction of lag vectors. Panels A-C show how lag vectors are constructed from the
autocorrelation function in the range w = 1 to 500. The solid circles on each graph show the values for
w = 100, 200, 300, 400, and 500.
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vides an even sharper contribution to the spectral estimate of Figure 2D. As can be ob-
served in Figure 2A, the autocorrelation function tends to diminish in amplitude with
greater lag ϕ, due to small prediction errors. Other investigators have used a damped
sinusoidal model for characterization of the autocorrelation function [25], but this is
not needed to construct the AFA spectral estimate, as damping and other changes are
already built into the lag vectors.
Introduction of antisymmetry
Although the NSE power spectrum has previously been shown useful for analysis of
atrial fractionation, subharmonics and cross-terms are present. To reduce these arti-
facts, the basis can be made antisymmetric [21]. Consider an ensemble average vector
ew with w even, composed of two segments aw/2 and bw/2, and let all vectors be row
vectors:
ew ¼ aw=2 bw=2
 ð10Þ
To impart antisymmetry to the second harmonic, the segments are averaged and the
result subtracted from each segment:
e
00
w ¼ ½aw=2 bw=2 −
1
2




aw=2 − bw=2 bw=2 − aw=2
 ð11Þ
where the double prime symbol ('') indicates that the ensemble vector is now antisym-
metric for the second harmonic. To show this, when the two components in Eq. 11 are
averaged, they form the 0 vector:






aw=2 − bw=2Þ þ bw=2 − aw=2Þ
 ð12Þ
If w is odd, then w/2 will not be an integer and will be subject to rounding error,which will introduce phase noise. To eliminate this drawback would require inter-
polation between data points so that real numbers are used, which for simplicity is not
done in this study.
Impartation of antisymmetry to higher harmonics is commutative and therefore is
not order-dependent. This can be shown by numerical example for harmonics 2 and 3.
The vectors shown below are row vectors. Consider a signal x:
x ¼ 1 2 3 4 5 6½  ð13Þ
The average of the second harmonic is:
h h2i ¼ 12 1 2 3½  þ
1
2










































The average of the third harmonic of x
00





























0 0;0 0 0 ¼ x0 0− h3i h3i h3i ¼ −1 −2 −1 1 2 1½ hhh½ ð18Þ
Both the second and third harmonics of the new vector are now antisymmetric:0 ¼ −1 −2 −1½  þ 1 2 1½ 
0 ¼ −1 −2½  þ −1 1½  þ 2 1½ 
ð19Þ
If the third harmonic of x is first made antisymmetric:
h h3i ¼ 13 1 2½  þ
1
3
3 4½  þ 1
3
5 6½  ¼ 3 4½  ð20Þ
Then:
x
0 0 0 ¼ x − h3i h3i h3ihhh½
¼ 1 2 3 4 5 6½  − 3 4 3 4 3 4½ 
¼ −2 −2 0 0 2 2½ 
ð21Þ
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0 0 0
is then made antisymmetric:
h h2i ¼ 12 −2 −2 0½  þ
1
2
0 2 2½  ¼ −1 0 1½  ð22Þ
Then:x
0 0 0; 0 0 ¼ x0 0 0− h2i h2i ¼ −1 −2 −1 1 2 1½ hh½ ð23Þ
where the right hand sides of Eq.’s 18 and 23 are identical. Therefore, the order of har-
monic removal is inconsequential, and antisymmetry is maintained for each harmonic
that is removed. If the basis contains little or no power in the second and third har-
monics, then h2ih , h3ih … will trend toward zero vectors, and there will be no signifi-
cant change in the shape of the original ensemble vector nor change in its power by
imparting antisymmetry.
In Figure 4 is shown an example of harmonic removal. A recording from the left su-
perior pulmonary vein, persistent AF patient is shown in panel A for 1000 sample
points. For this signal the DF is 5.96 Hz (w = 164). The ensemble average at the DF
after antisymmetry is imparted to the second harmonic is shown repeated in panel B.
Addition of the two antisymmetric components, each of length 164 / 2 = 82 points,
forms the zero vector, shown in panel C. When antisymmetry is imparted to the en-
semble averages prior to power spectral calculation, the resulting spectral estimator is
termed the novel spectral estimator with harmonics removed (NSH).
Implementation of estimators and spectral measurements
The aforementioned spectral estimators were compared to the Fourier power spectrum,
which was computed using a radix-2 implementation of the DFT [26]. For ease ofFigure 4 Example of removal of harmonics from the ensemble average of the DF, which is done for
the NSH estimator implementation. Panel A: Original signal. Panel B: The ensemble average of the
dominant frequency with antisymmetry imparted to the second harmonic. Panel C: Addition of the
antisymmetric components of the ensemble average in panel B results in the zero vector.
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lution was not diminished [20]. Furthermore, for better comparison, the preprocessing
step of bandpass filtering, signal rectification, and low pass filtering [12,13] was not
implemented. For calculation of spectral parameters, for simplicity the NSH estimator
was implemented with antisymmetry imparted to the second harmonic only, where
most of the harmonic power resides.
The following parameters were used for comparison of the spectral estimators in the
physiologic range of 3-12 Hz. The DF was determined by automatically selecting the
tallest spectral peak in the range 3.5-8.5 Hz [21] with manual correction when neces-
sary if the fundamental frequency was found to reside between 3–3.5 Hz or between
8.5-12 Hz (in practice it is almost always found between 3.5-8.5 Hz). This practical im-
plementation solves the problem of inadvertently selecting a subharmonic as the DF
during the automatic detection process, as was done in a previous study [27]. The domi-
nant amplitude (DA) was also measured, defined as the amplitude of the DF peak [21]. A
larger value of DA indicates that more signal power resides in the dominant periodic
component, as can occur when a stable local electrical activation pattern is the source.
The magnitude of the power spectrum from 3-12 Hz was then normalized to a range of
0–1 units. The mean of this normalized spectral profile (MP), which is indicative of the
spectral baseline level and therefore the degree of global electrical activation pattern sta-
bility [21], was also calculated.Figure 5 Examples of power spectra for the four estimators. The spectra are shown in the range
2 – 20 Hz for clarity.
Table 1 Dominant amplitude
Method MN - Par SD - Par MN - Per SD – Per MN Signif SD Signif
NSE 1.472 0.231 1.839 0.604 p < 0.001 p < 0.001
NSH 1.192 0.225 1.521 0.483 p < 0.001 p < 0.001
AFA 0.141 0.172 1.173 4.637 p = 0.140 p < 0.001
DFT 0.688 0.297 0.849 0.375 p = 0.004 p = 0.064
Par paroxysmal AF, Per persistent AF, MN mean, SD standard deviation, Signif significance. For DA and DF, only
pulmonary vein ostia recordings were used and N = 60 and 76, respectively, for paroxysmal versus persistent CFAE.
For MP, all sites were used and N = 90 and 114, respectively, for paroxysmal versus persistent CFAE.
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As a further check of the methods, the CFAE were then subdivided according to mor-
phologic differences. All CFAE were first scaled to a peak-to-peak value of 1.0 milli-
volts. Fast activation rate CFAE were defined as those scaled electrograms with a
standard deviation < 0.074. Highly fractionated CFAE were defined as those scaled elec-
trograms with a standard deviation ≥ 0.074. The threshold was taken so as to subdivide
the number of CFAE in each subgroup evenly (102 electrograms in each group). This
quantitative definition corresponded to the visual appearance of these electrograms.
For each of the two subgroups, the same spectral parameters were compared for paroxys-
mal versus persistent CFAE using all four estimators.Statistical calculations
The DFT, NSE, NSH, and AFA estimators were compared statistically based on the
three measured spectral parameters. The Mann–Whitney Rank Sum Test, a nonpara-
metric procedure which does not require assumption of normality or equal variance,
was used to determine significant differences in the means in the spectral parameters,
and the F-test was used to determine significant differences in the standard deviations
(SigmaPlot 2004 for Windows Ver. 9.01, Systat Software, Chicago, MedCalc ver. 9.5,
2008, MedCalc Software bvba, Mariakerke, Belgium). Differences were considered sig-
nificant at a level p < 0.05.Results
An example of the power spectra for each of the estimators using a repetitive electro-
gram pattern having a frequency of 4.89 Hz is shown in Figure 5. This example was
used to show that each estimator could detect the DF. From panels A to D are spectra
from NSE, NSH, AFA, and DFT estimators. The frequency range is 2 – 20 Hz to
show presence of sub- and superharmonics. For all spectra, the tallest peak in theTable 2 Dominant frequency
Method MN - Par SD - Par MN - Per SD - Per MN Signif SD Signif
NSE 5.741 1.235 6.196 0.969 p < 0.001 p = 0.047
NSH 5.732 1.274 6.420 0.977 p < 0.001 p = 0.030
AFA 5.317 1.182 5.962 1.176 p < 0.001 p = 0.959
DFT 5.623 1.126 6.253 0.919 p < 0.001 p = 0.096
Par paroxysmal AF, Per persistent AF, MN mean, SD standard deviation, Signif significance. For DA and DF, only
pulmonary vein ostia recordings were used and N = 60 and 76, respectively, for paroxysmal versus persistent CFAE.
For MP, all sites were used and N = 90 and 114, respectively, for paroxysmal versus persistent CFAE.
Table 3 Mean spectral profile
Method MN - Par SD - Par MN – Per SD - Per MN Signif SD Signif
NSE 0.401 0.062 0.337 0.104 p < 0.001 p < 0.001
NSH 0.375 0.069 0.308 0.096 p < 0.001 p = 0.001
AFA 0.358 0.088 0.304 0.099 p < 0.001 p = 0.247
DFT 0.305 0.068 0.258 0.071 p < 0.001 p = 0.674
Par paroxysmal AF, Per persistent AF, MN mean, SD standard deviation, Signif significance. For DA and DF, only
pulmonary vein ostia recordings were used and N = 60 and 76, respectively, for paroxysmal versus persistent CFAE.
For MP, all sites were used and N = 90 and 114, respectively, for paroxysmal versus persistent CFAE.
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tive pattern. The 2.45 Hz subharmonic is evident in NSE and AFA spectra. Cross-terms
are also present in the NSE spectrum, for example at 3.26 Hz (2/3 integer relationship
with the DF) and 12.23 Hz (5/2 integer relationship with the DF). Subharmonics and
cross-terms are mostly absent from the NSH spectrum, which for illustrative purposes
was constructed using antisymmetric bases for the 2nd, 3rd, 5th, and 7th harmonics.Summary statistics
Measurements for all data are shown in Tables 1, 2 and 3. The DA spectral parameter
results are summarized in Table 1. For all measurement methods, mean DA was greater
in persistent as compared with paroxysmal AF. This was highly significant for the NSE
and NSH estimators (p < 0.001). The standard deviation in the DA spectral parameter
was greater in persistent AF as compared with paroxysmal AF for all methods. This
was highly significant (p < 0.001), except for the DFT estimator which was not signifi-
cant. For all measurement methods, the mean DF was also greater in persistent AF as
compared with paroxysmal AF (Table 2). This was highly significant for all methods
(p < 0.001). The standard deviation in DF was larger in paroxysmals for all methods,
which achieved moderate significance only for NSE and NSH (p < 0.05). Measurements
for the MP spectral parameter are shown in Table 3. For all methods, mean MP was
greater in paroxysmal as compared with persistent AF patients. The differences in
mean MP were highly significant for all four methods (p < 0.001). The differences in
the standard deviation of MP were highly significant for the NSE and NSH estimators
(p ≤ 0.001).
Overall, the NSE and NSH methods had highly significant differences in the means
for DA, DF, and MP (p<0.001). The AFA and DFT methods had highly significant dif-
ferences in the means for DA and MP only (p<0.001). Overall, NSE and NSH had
highly significant differences in the standard deviations for DA and MP (p<0.001) and
moderately significant difference for DF (p<0.05)s. AFA had a highly significant dif-
ference in standard deviation for the DA measurement. The DFT had no significantTable 4 Fast activation rate - dominant amplitude
Method MN - Par SD – Par MN - Per SD - Per MN Signif SD Signif
NSE 1.453 0.210 1.679 0.442 P = 0.008 P < 0.001
NSH 1.175 0.208 1.411 0.415 P = 0.003 P < 0.001
AFA 0.012 0.016 0.106 0.563 P = 0.412 P < 0.001
DFT 0.688 0.299 0.741 0.368 P = 0.600 P = 0.099
Par paroxysmal AF, Per persistent AF, MN mean, SD standard deviation, Signif significance.
Table 5 Fast activation rate - dominant frequency
Method MN - Par SD - Par MN - Per SD - Per MN Signif SD Signif
NSE 5.689 1.225 6.352 1.031 P = 0.003 P = 0.158
NSH 5.545 1.337 6.665 0.949 p < 0.001 P = 0.005
AFA 5.028 1.025 6.004 1.229 p < 0.001 P = 0.148
DFT 5.444 1.068 6.454 0.982 p < 0.001 P = 0.489
Par paroxysmal AF, Per persistent AF, MN mean, SD standard deviation, Signif significance.
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cant differences in spectral estimation measurements between paroxysmal and persis-
tent AF, the NSE and NSF methods had greatest efficacy, followed by AFA and DFT.
Tables 4, 5 and 6 show the results for fast activation rate CFAE only. Similar to
Tables 1, 2 and 3, there are higher values for DA and DF in persistent AF for all estima-
tors, and higher values of MP in paroxysmal AF for all estimators. The NSE and NSH
estimators exhibit significant differences in paroxysmals versus persistents for all three
spectral parameters. The AFA and DFT estimators exhibit significant differences in par-
oxysmals versus persistents for only the DF spectral parameter. Tables 7, 8 and 9 show
the results for highly fractionated CFAE only. Similar to Tables 1, 2 and 3 and Tables 4,
5 and 6, there are higher values for DA and DF in persistent AF for all estimators, and
higher values of MP in paroxysmal AF for all estimators. The NSE, NSH, and DFT esti-
mators exhibit significant differences in paroxysmals versus persistents for two of three
spectral parameters. The AFA estimator exhibits significant differences in paroxysmals
versus persistents for one of three spectral parameters – the MP. For both subgroups
(Tables 4, 5 and 6 and Tables 7, 8 and 9), overall there were significant differences in
standard deviations at the p<0.01 level in 5/6 comparisons for the NSE and NSH esti-
mators, in 2/6 comparisons for the AFA estimator, and in 1/6 comparisons for the DFT
estimator.Discussion
Summary
In this study, novel methods of spectral estimation were compared to traditional Fou-
rier analysis for characterization of complex fractionated electrograms recorded during
atrial fibrillation. The foundation for these novel techniques is a recently described
transform in which the power spectrum is computed by averaging the autocorrelation
function at lags [19]. Since the DFT estimator models the autocorrelation function
using a sinusoidal approximation (Wiener–Khinchin theorem), all four spectral estima-
tors are derived from the autocorrelation function. Three spectral parameters were
used to test the efficacy of each spectral estimator. Along with the DF which is
commonly used, two additional spectral measurements, the DA and MP, were alsoTable 6 Fast activation rate - mean spectral profile
Method MN – Par SD – Par MN - Per SD - Per MN Signif SD Signif
NSE 0.400 0.057 0.352 0.091 P = 0.004 P < 0.001
NSH 0.382 0.062 0.319 0.089 p < 0.001 P < 0.001
AFA 0.369 0.087 0.340 0.086 P = 0.094 P = 0.902
DFT 0.307 0.076 0.277 0.066 P = 0.054 P = 0.156
Par paroxysmal AF, Per persistent AF, MN mean, SD standard deviation, Signif significance.
Table 7 Highly fractionated - dominant amplitude
Method MN - Par SD – Par MN - Per SD - Per MN Signif SD Signif
NSE 1.509 0.270 2.037 0.716 p < 0.001 P < 0.001
NSH 1.226 0.259 1.658 0.530 p < 0.001 P < 0.001
AFA 0.027 0.025 0.185 0.555 P = 0.084 P < 0.001
DFT 0.688 0.301 0.984 0.343 p < 0.001 P = 0.298
Par paroxysmal AF, Per persistent AF, MN mean, SD standard deviation, Signif significance.
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and standard deviations of the measurements when comparing paroxysmal versus per-
sistent AF data. Two of the methods, NSE and NSH, were significantly improved with
respect to the DFT for discerning CFAE spectral parameters in paroxysmal versus per-
sistent AF patients. Although the AFA method, calculated over a signal length 2N, pro-
vided only marginal improvement as an estimator as compared with the DFT, it is
simple to implement, requiring only one line of software code to describe the calcula-
tion (Eq. 9).Clinical correlates
Although the DF is often used for frequency analysis of CFAE, our study suggests that
other spectral parameters may be more useful for fractionated atrial electrogram ana-
lysis. The DA parameter is related to DF power, and is therefore somewhat similar to
the regularity index sometimes used in previous studies [14,28]. The regularity index is
defined as the power of the dominant peak divided by the overall spectral power. How-
ever the regularity index requires the width of the dominant peak to be guesstimated.
Furthermore, the regularity index is normalized over an arbitrary power spectral range.
No such guesstimates and arbitrary impositions are used for DA calculation, so that it
is potentially a more robust measure for clinical application. The MP parameter was
measured over the accepted electrophysiologic range of 3-12 Hz [21]. It is therefore a
more global spectral measure as compared with the DA and DF parameters, and as
such is more similar to the organizational index described in previous studies [14,28].
The organizational index is defined as the spectral power of the DF and its harmonics
divided by the overall spectral power. The organizational index however, involves
guestimation of the width of the dominant peak, as well as the width of harmonics
whose power should be summed, and the number of harmonics to be summed. In con-
trast, the MP spectral parameter does not use guesstimates, so that it is likely to be a
more robust measure for clinical application.
The NSE transform for spectral estimation and signal reconstruction has also been
applied to other applications including ventricular tachyarrhythmias [29] and to video-
capsule imagery data in celiac disease patients [30]. The method is therefore likelyTable 8 Highly fractionated - dominant frequency
Method MN - Par SD – Par MN - Per SD - Per MN Signif SD Signif
NSE 5.845 1.281 6.003 0.863 P = 0.591 P = 0.001
NSH 6.106 1.073 6.118 0.939 P = 0.936 P = 0.274
AFA 5.896 1.285 5.910 1.122 P = 0.781 P = 0.266
DFT 5.981 1.181 6.005 0.778 P = 0.914 P = 0.001
Par paroxysmal AF, Per persistent AF, MN mean, SD standard deviation, Signif significance.
Table 9 Highly fractionated - mean spectral profile
Method MN - Par SD – Par MN - Per SD - Per MN Signif SD Signif
NSE 0.401 0.068 0.323 0.113 p < 0.001 P < 0.001
NSH 0.368 0.076 0.297 0.101 p < 0.001 P = 0.006
AFA 0.345 0.088 0.272 0.099 p < 0.001 P = 0.247
DFT 0.302 0.057 0.240 0.071 p < 0.001 P = 0.031
Par paroxysmal AF, Per persistent AF, MN mean, SD standard deviation, Signif significance.
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have also been used for QRST cancellation [31] and the NSE estimator has been incor-
porated into a study for heart sounds quantification [32]. Heart sounds patterns have
also been detected by averaging segments of the acoustic signal at different lengths w,
similar to the NSE implementation [33].Limitations
The General Electric CardioLab acquisition settings are hardwired for signal digitiza-
tion at a rate of 977 Hz after antialiasing with a single pole filter having a 500 Hz corner
frequency. These settings cause any high frequency components from 489 – 500 Hz to
pass through the filter without sufficiently fast digitization for accurate representation, a
limitation of the system. The study was done using retrospective data and with a relatively
small number of patient recordings. The results should be confirmed in a larger, pros-
pective study.Conclusions
Measurements made from all four spectral estimators used in the study were in agree-
ment as to whether the means and standard deviations in three spectral parameters
were greater in paroxysmal or in persistent AF. Since the measurements were consis-
tent, implementation of several of these estimators for power spectral analysis should
be useful for verification of the findings. Since the most significant differences overall
were achieved using the NSE and NSH estimators, parameters measured from their
spectra will likely be the most helpful for detecting and discerning electrophysiologic
differences in the AF substrate. For all methods, to varying degrees of significance,
the DP parameter was greater and the DF higher in persistent AF, while the MP
was larger in paroxysmal AF, likely reflecting a greater uniformity in remodeling and
greater stability of the activation pattern in the arrhythmogenic substrate of persis-
tent AF patients.
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